Considering that albumin is a predictive factor of NAFLD worsening [69], we also proceeded with a liver protein profile—total protein, albumin, and globulin—to check if the supplements would have any effect, and even whether in our mouse model of hepatic steatosis could be altered. The gene discussed is ALB; the disease is fatty liver disease.